Stryker’s (NYSE:SYK) Australian arm provided national health regulators with updated recommendations for monitoring patients who received the company’s now-recalled ABG II Modular hip systems.
Orthopedics
Welcome to MassDevice's Orthopedics Hub, your resource for the latest in orthopedic news. Stay informed about the innovations and business news shaping the ortho device industry.
🦴 Narrow your focus with these categories:
Implants | Metal-on-Metal | Spine
Here are the top orthopedic device features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ The biggest stories from AAOS 2024
+ The 10 largest orthopedic device companies in the world
+ The ZimVie Tether helps kids with scoliosis — if they can get it in time
+ Could 2023 be a boom year for orthopedic devices?
+ The top orthopedic device news out of AAOS 2023
Latest Orthopedics News
Bonesupport lands CE Mark for next-gen antibiotic bone graft substitute
Swedish orthopedic trauma products maker Bonesupport won CE Mark approval in the European Union for its next-generation Cerament|G injectable antibiotic-eluting bone substitute.
The Cerament|G product is an osteoconductive, ceramic substance designed to promote bone healing while preventing bone infection, or osteomyelitis The resorbable bone graft substitute is designed to remodel into healthy bone within 6-12 months while preventing colonization of microorganisms, especially in cases of deep bone infection.
ArthroCare shares flat on DoJ overhang despite swings to Q4, 2012 black
Investors stayed on the sidelines last week on shares of ArthroCare (NSDQ:ARTC), despite its return to black ink for both the 4th quarter and full year, as they awaited more information on pending U.S. Justice Dept. investigations.
More hip recalls for Johnson & Johnson?
International reports today suggest that healthcare giant Johnson & Johnson (NYSE:JNJ) recalled its Adept hip replacement system, another in its line of troubled metal-on-metal hip implants.
Lawsuit: Stryker should cover Fla. patients’ medical monitoring over recalled Rejuvenate hip implant
Smith & Nephew’s Q4 profits down, 2012 profits flat
Smith & Nephew (FTSE:SN, NYSE:SNN) shares are up slightly in The City and down a tick on The Street, after the British orthopedics giant reported flat profits for 2012 and a slight decline for the 4th quarter, excluding 1-time costs from acquisitions and restructuring.
Knee replacement: Stanmore nabs FDA clearance for robotic guidance system
U.K.-based orthopedic device maker Stanmore Implants says it has received FDA clearance for its Sculptor Robotic Guidance Arm system for partial knee resurfacing procedures.
The system uses a robotic guidance arm to assist surgeons’ operation of cutting tools, and "limiting the removal of bone to a pre-defined safe area," according to a prepared release. It is part of a suite of devices and software systems the company produces for personalized orthopedic implants.
Super Bowl winners: DJO Global scores with Ray Lewis’ custom brace
Super Bowl advertisers spent about $4 million for each 30-second spot during the big game Sunday, but 1 medical device company scored far more airtime with some pretty savvy product placement on 2 of the game’s biggest stars.
DonJoy, a division of Vista, Calif.-based DJO Global, outfitted both Baltimore Ravens linebacker Ray Lewis and San Francisco 49ers defensive tackle Justin Smith with custom versions of its X-Act ROM elbow brace. Both players had suffered torn triceps earlier in the season.
Ivantis reels in $27M Series B round | Wall Street Beat
Ivantis said it raised a $27 million Series B round led by Ascension Health Ventures aimed at funding a quartet of clinical trials for its Hydrus Microstent glaucoma treatment.
The Irvine, Calif.-based medical device company said the device, an eyelash-sized stent, is designed to reduce eye pressure.
ArthroCare DOJ beef gets a new deadline
Surgical devices maker ArthroCare (NSDQ:ARTC) this month agreed to extend for 1 more month the statute of limitations on a federal inquiry from the U.S. Dept. of Justice in to the company’s spinal business.
Zimmer slides on lower spine market outlook
Shares of Zimmer (NYSE:ZMH) slipped about 1% today after the medical device company revealed a 7% slide last year for its spine unit and said it expects the spine slump to continue in 2013.
The stock decline came despite results that exceeded Wall Street’s forecast for both the 4th quarter and 2012.